Literature DB >> 16319096

Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab.

C Pérez-García, J Maymo, M P Lisbona Pérez, M Almirall Bernabé, J Carbonell Abelló.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16319096     DOI： 10.1093/rheumatology/kei220

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 2.  A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?

Authors:  Tânia Santiago; Mariana Galante Santiago; João Rovisco; Cátia Duarte; Armando Malcata; José António Pereira da Silva
Journal:  Clin Rheumatol       Date:  2013-08-17       Impact factor: 2.980

3.  Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.

Authors:  Hatice Bodur; Filiz Eser; Sefika Konca; Serpil Arikan
Journal:  Rheumatol Int       Date:  2008-08-21       Impact factor: 2.631

4.  Spondyloarthropathies in autoimmune diseases and vice versa.

Authors:  Oscar M Pérez-Fernández; Rubén D Mantilla; Paola Cruz-Tapias; Alberto Rodriguez-Rodriguez; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2012-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.